A Phase 2, Double-Blind, Placebo-Controlled, Parallel Dose Study to Evaluate the safety and Efficacy of RT001 Gel for the Treatment of Allergic Rhinitis
Latest Information Update: 23 Jun 2016
Price :
$35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Allergic rhinitis
- Focus Therapeutic Use
- 06 Nov 2012 New trial record